INAB vs GILD: Which Stock is Better?
Side-by-side comparison of In8Bio Inc and Gilead Sciences Inc in 2026
INAB
In8Bio Inc
$1.40
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | INAB | GILD | Winner |
|---|---|---|---|
| Market Cap | $13.29M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze INAB
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INAB or GILD a better investment?
Comparing INAB and GILD: In8Bio Inc has a market cap of $13.29M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INAB and GILD?
INAB (In8Bio Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INAB or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INAB or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for INAB.
Which company is more profitable: INAB or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for INAB.
Which is the larger company: INAB or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $13.29M for INAB.
Should I buy INAB or GILD in 2026?
Both INAB and GILD have investment merit. INAB trades at $1.40 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INAB and GILD stock?
Key differences: Market Cap ($13.29M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).